The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - Ability Pharma; AstraZeneca/MedImmune; Bayer; Torus Pharma
Speakers' Bureau - Genentech; Incyte
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); FibroGen (Inst); Genentech (Inst); Incyte (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst)
 
Khaled Fahmy Abouelezz
No Relationships to Disclose
 
Katie Moreland
No Relationships to Disclose
 
Ralph Quillin
No Relationships to Disclose
 
Kristina Lemon
No Relationships to Disclose
 
Adam Rojan
Research Funding - Isofol Medical (Inst); Merck (Inst)
 
Olugbenga Olanrele Olowokure
No Relationships to Disclose
 
Ali Kord
No Relationships to Disclose
 
Shimul Shah
No Relationships to Disclose